PLSH (Panacea Life Sciences Holdings) Long-Term Debt: $0.00 Mil (As of Sep. 2025)


What is Panacea Life Sciences Holdings Long-Term Debt?

Panacea Life Sciences Holdings PLSH +11.11% Long-Term Debt is $0.00 Mil as of Sep. 2025. The stock has 6 warning signs investors should review.

Panacea Life Sciences Holdings's Long-Term Debt for the quarter that ended in Sep. 2025 was $0.00 Mil.

Panacea Life Sciences Holdings's quarterly Long-Term Debt declined from Mar. 2025 ($3.06 Mil) to Jun. 2025 ($0.00 Mil) but then stayed the same from Jun. 2025 ($0.00 Mil) to Sep. 2025 ($0.00 Mil).

Panacea Life Sciences Holdings's annual Long-Term Debt increased from Dec. 2021 ($3.26 Mil) to Dec. 2022 ($3.57 Mil) but then stayed the same from Dec. 2022 ($3.57 Mil) to Dec. 2023 ($3.57 Mil).

Panacea Life Sciences Holdings  (OTCPK:PLSH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Panacea Life Sciences Holdings Long-Term Debt Related Terms

Panacea Life Sciences Holdings Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Long-Term Debt Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Long-Term Debt
2.70 3.26 3.57 3.57

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.57 3.57 3.06 0.00 0.00
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Long-Term Debt of $0.00 Mil as of Sep. 2025.
Is Panacea Life Sciences Holdings' Long-Term Debt too high?
Panacea Life Sciences Holdings' current Long-Term Debt is $0.00 Mil.
How does Panacea Life Sciences Holdings' Long-Term Debt compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Long-Term Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Panacea Life Sciences Holdings's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Long-Term Debt is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.